Brain Implants Market Set to Reach US$ 17.65 Billion by 2030 at 11.8% CAGR

The global brain implants market is expanding as neuroscience and neurotechnology continue to advance and neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and epilepsy become increasingly prevalent. Brain implants provide potential therapeutic solutions by modifying neural activity and helping restore normal brain function. Growing awareness of the benefits of brain implants, together with developments in neural implant technologies, is supporting market expansion across global healthcare systems. North America held a significant position in the global market, accounting for 43.5% of the market share in 2022.

According to The Insight Partners, the Brain Implants Market size is projected to grow from US$ 7,205.80 million in 2022 to US$ 17,647.65 million by 2030, registering a CAGR of 11.8% during 2022–2030. The increasing incidence of neurological diseases, growth in the geriatric population, and rising use of neural implants for disease treatment, memory improvement, and prosthetic limb communication are contributing to the development of the Brain Implants Market.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPHE100001259

Brain Implants Market Size and Growth:

The Brain Implants Market is expected to demonstrate substantial growth throughout the forecast period. From a market size of US$ 7,205.80 million in 2022, the market is projected to reach US$ 17,647.65 million by 2030, reflecting a CAGR of 11.8%. The market growth is associated with the increasing prevalence of neurological conditions and continued advancements in neuroscience and neurotechnology.

Deep brain stimulation is an important area of brain implant development, particularly for neurological conditions such as Parkinson’s disease. The report highlights growing reliance on deep brain stimulation as a treatment approach and identifies opportunities associated with the introduction and use of additional neural implants for memory improvement, disease treatment, and prosthetic limb communication.

Brain Implants Market Drivers:

One of the key factors supporting the Brain Implants Market is the increasing prevalence of neurological disorders among the aging population. Alzheimer’s disease, epilepsy, Parkinson’s disease, and dystonia are among the neurological disorders affecting the geriatric population. The report also highlights the increasing incidence of neurological conditions in countries such as the US and Canada as an important factor influencing demand for brain implant technologies.

The increasing number of spinal cord injuries and demand for spinal cord stimulation are also contributing to market development. Spinal cord stimulation can help manage chronic pain when conventional treatment cannot completely address the underlying condition. The availability of medical reimbursements, together with increasing cases of spinal illnesses and chronic lower back pain, supports the growth of the spinal cord stimulation segment.

Brain Implants Market Segmentation:

The Brain Implants Market is segmented by treatment, application, end user, and geography. By treatment, the market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, invasive and noninvasive brain-computer interfaces, responsive neurostimulation for seizures, auditory brainstem implants, and ophthalmic aids or implants.

By application, the market covers chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis, and neurofibromatosis 2. By end user, the market is divided into hospitals and specialized clinics or neurological centers. Geographically, the market covers North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa.

Brain Implants Market Share and Segment Analysis:

Spinal cord stimulation accounted for the largest share of the Brain Implants Market by treatment in 2022, representing 37.6% of the market. Meanwhile, the invasive and noninvasive brain-computer interfaces segment is estimated to register the highest CAGR during 2022–2030. By application, chronic pain held the largest market share in 2022 at 38.3%, while the Alzheimer’s disease segment is expected to register the highest CAGR during the forecast period.

Hospitals held a larger market share among end users in 2022 and are anticipated to grow at a higher CAGR during 2022–2030. Hospitals provide diagnosis, treatment, pre-operative and post-operative care, monitoring, programming, and follow-up services for patients receiving brain implants. They also support research and clinical trials related to brain implant technologies.

Brain Implants Market Growth and Opportunities:

Technological advancements, research activities, and increasing applications of neural implants are creating opportunities across the Brain Implants Market. North America captured a significant market share in 2022, while Asia Pacific is projected to grow at a CAGR of 12.8% during the forecast period. The United States market is projected to grow at a CAGR of 12.2%.

Developments by industry participants are also contributing to market evolution. In June 2023, Boston Scientific received US FDA approval for the Vercise Neural Navigator 5 Software used with Vercise Genus Deep Brain Stimulation Systems. In January 2021, Medtronic announced enrollment in ADAPT-PD to evaluate adaptive DBS in patients with Parkinson’s disease.

Buy Premium Report: https://www.theinsightpartners.com/buy/TIPHE100001259

Top Key Players in the Brain Implants Market:

The Brain Implants Market includes several prominent companies involved in developing brain implant technologies, products, and related solutions.

Key players profiled in the report include Boston Scientific Corporation, Medtronic, Abbott Laboratories, Functional Neuromodulation Ltd., Fisher Wallace Laboratories Inc., Synchron Inc., Blackrock Microsystems Inc., Renishaw Plc., NeuroPace Inc., Aleva Neurotherapeutics SA, NeuroSpine LLC, CorTec GmbH, NeuroSky Inc., Neuralink Corp., ONWARD Medical NV, and Paradromics Inc. These companies focus on new high-technology products, advancements in existing technologies, and geographic expansion to address growing demand for brain implant solutions.

Future Outlook :

The Brain Implants Market is expected to continue expanding through 2030 as neurological disease prevalence, geriatric populations, research activity, and technological advancements support demand for neural implant technologies. The projected increase from US$ 7,205.80 million in 2022 to US$ 17,647.65 million by 2030 demonstrates the expanding market opportunity, while the 11.8% CAGR indicates sustained growth during the forecast period.

Trending Reports:

· Botulinum Toxin Market Key Players and Opportunities by 2031

· Brachytherapy Devices Market Share, Size & Demand by 2034

· Brain Implants Market Dynamics and Developments by 2030

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.